article thumbnail

Cannabinoid Breakdown- Analyzing the DEA’s Position on Novel Cannabinoids

Cannabis Law Report

Despite its brevity, the DEA letter I received last week about THCO was followed by confusion and lots of speculation in the cannabis industry about the legal status of novel and mood-altering cannabinoids. In this article, I […]

article thumbnail

New DEA Report Says Border Seizures of Mexican Weed Have Fallen By 80 Percent

SpeedWeed

Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Scientists Think the Synthetic Cannabinoids in Sativex Can Beat Brain Cancer

SpeedWeed

In other positive news on this front, earlier this year the DEA announced that additional US companies would be allowed to supply scientists with cannabis for scientific research. View original article. The post Scientists Think the Synthetic Cannabinoids in Sativex Can Beat Brain Cancer appeared first on SpeedWeed.

article thumbnail

The Key Differences Between CBD and THC You Need to Know

United Patients Group

THC is the chemical aka cannabinoid in cannabis that gives off the psychoactive feeling. THC is known to interact with the cannabinoid 1 (CB1) receptors in the brain, eliciting a feeling of euphoria and a sense of being high. However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification.

THC 117
article thumbnail

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45
article thumbnail

Hemp-CBD: Deadline Approaching to Submit Comments on USDA Interim Hemp Rule

Canna Law Blog

Here is a good article by Hemp Grower magazine on the reopening). Nathalie Bougenies recently wrote about a lawsuit filed against the DEA by the Hemp-CBD industry and we have written several times about the problems with the DEA’s rule: Watch Out! The DEA Does Not Want You To Worry About Its New Hemp Rule.

Hemp 88
article thumbnail

Lisa’s List: Industry News Update – August 2022

Cannabis Law Report

My latest selection of links to articles and updates around the country in August. Cannabinoids. Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. DEA grants research license for psychedelics and major depression first human trial: [link].

DEA 98